During the past decade, Vance Thompson Vision conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Vance Thompson Vision" are "Aphakia" (1 trials), "Cataract" (1 trials), "Corneal Endothelial Dystrophy" (1 trials), "Dry Eye" (1 trials) and "Endothelial Dysfunction" (1 trials). Many other conditions were trialed in "Vance Thompson Vision" in a lesser frequency.

Most popular intervention types in "Vance Thompson Vision" are "Drug" (3 trials), "Device" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "TTHX1114(NM141)" (2 trials), "Control IOL" (1 trials), "Light Adjustable lens (LAL) and Light Delivery Device (LDD)" (1 trials), "OC-01 (varenicline 0.6mg/ml) nasal spray" (1 trials) and "Placebo (vehicle) Nasal Spray" (1 trials). Other intervention names were less common.

The vast majority of trials in "Vance Thompson Vision" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Vance Thompson Vision". undefined are not yet recruiting, 2 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Vance Thompson Vision, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Vance Thompson Vision, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".